Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Shire Added to Global 100 Sustainability Index

22nd Jan 2015 07:00

SHIRE PLC - Shire Added to Global 100 Sustainability Index

SHIRE PLC - Shire Added to Global 100 Sustainability Index

PR Newswire

London, January 21

Shire Added to Global 100 Sustainability Index Lexington, MA and Zug, Switzerland - January 21, 2015 - Shire plc (LSE: SHP,NASDAQ: SHPG) announces that it has for the first time placed in the Global 100Sustainability Index. Shire was ranked 62nd in the index, which is beingrevealed during the World Economic Forum in Davos this week. The Global 100 Index is a global ranking by Canada-based media and investmentadvisory company, Corporate Knights, of the top sustainability performers andhas come to be recognised as the gold standard in corporate sustainabilityanalysis. The Global 100 Index is determined from public data using twelvequantitative sustainability indicators which include leadership diversity,employee compensation, tax paid, innovation capacity, and energy and water use,among others. Shire's Chief Executive Officer, Flemming Ornskov, MD, MPH, commented: "We appreciate the recognition for Shire's approach to being a sustainable,responsible business. Our patients rely on us and our products to live betterlives, and having an ethical and responsible approach to our daily activities,policies and programs is fundamental for our future, our patients' future, andthe wider global community." Read more about Shire's approach to Responsibility at www.shire.com/cr For further information please contact: Media Brooke Clarke [email protected] +44 1256 894 829 Robert Stanislaro [email protected] +1 646 421 9067 Irma Gomez-Dib [email protected] +1 415 706 9155 NOTES TO EDITORS Shire enables people with life-altering conditions to lead better lives. Our strategy is to focus on developing and marketing innovative specialtymedicines to meet significant unmet patient needs. We focus on providing treatments in Rare Diseases, Neuroscience,Gastrointestinal, and Internal Medicine and we are developing treatments forsymptomatic conditions treated by specialist physicians in other targetedtherapeutic areas, such as Ophthalmics. www.shire.com Registered in Jersey, No. 99854, 22 Grenville Street, St Helier, Jersey JE4 8PX Press Release www.shire.com

Related Shares:

Shire
FTSE 100 Latest
Value8,610.15
Change7.23